MedPath

A clinical study for evaluating the safety of excessive intake of fermented milk drink. -Open study

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000024347
Lead Sponsor
KSO Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who regularly use intestinal drugs or laxatives. 2) Subjects who have severe complication or serious diseases requiring an urgent treatment. 3) Subjects who have a chronic disease and use medicines constantly. 4) Subjects who have medical history of diseases or surgeries which affect digestion and absorption. 5) Subjects who repeat constipation and diarrhea such as irritable colitis. 6) Subjects who regularly use functional foods which help relieve constipation (including Food for Specified Health Uses, Foods with Function Claims) 7) Subjects who take drugs which affect digestion and absorption such as antibiotics at screening test. 8) Subjects who can't stop ingesting food containing lactic acid bacteria, bifidobacteria, oligosaccharide and viable bacteria, large amounts of sugar alcohol or functional foods (including Food for Specified Health Uses, Foods with Function Claims) which help relieve constipation. 9) Subjects who are under treatment for or have a history of drug addiction and/or alcoholism. 10) Subjects who have tendency to get diarrhea by ingesting milk. 11) Subjects who have food allergy. 12) Subjects who are judged as unsuitable for the study by screening questionnaire. 13) Subjects who are judged as unsuitable for the study by the blood test results of screening test. 14) Subjects who are planning to become pregnant during the study or are pregnant or lactating. 15) Subjects who are planning to participate or already participating in other clinical studies. 16) Subjects who are judged as unsuitable for the study by the investigator for other reasons.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath